Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of Bcell malignancies (Review)

Author：

E-ISSN： 1792-1082|10|6|3339-3344

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.6, 2015-01, pp. : 3339-3344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bruton's Tyrosine Kinase as a New Therapeutic Target

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 6, 2007-11 ,pp. : 624-632

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors in Pediatric Malignancies

By Skolnik Jeffrey Adamson Peter

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 606-612

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Targeting PAK Signaling

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 1, 2016-01 ,pp. : 75-88

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 6, 2011-07 ,pp. : 560-575

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond

By Katz Ben-Zion Herishanu Yair

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 999-1006

Informa Healthcare

Access to resources Recommend Favorite